Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms × Amantadine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Surveys and Questionnaires 74 Blood Specimen Collection 49 Interviews as Topic 26 Data Collection 15 Radiotherapy 12 Observation 12 Magnetic Resonance Spectroscopy 11 Hematologic Tests 11 Exercise 11 Watchful Waiting 9 Drug Therapy 9 Quality of Life 8 Specimen Handling 7 Biopsy 7 Therapeutics 6 Focus Groups 6 pembrolizumab 5 Restraint, Physical 5 Phlebotomy 5 Nivolumab 5 Magnetic Resonance Imaging 5 Lapatinib 5 atezolizumab 4 Trastuzumab 4 Standard of Care 4 Rivaroxaban 4 Palliative Care 4 Neoadjuvant Therapy 4 Mental Status and Dementia Tests 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02277938 2021-03-17

Acetylamantadine Excretion by Cancer Patients

University of Manitoba

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡